Table 3 Differences in impairment among females compared to males, presented as estimate or odds ratio (OR) when indicated with (95% confidence interval) and p-values for each outcome. Estimates that are statistically significant (p < 0.05) are bolded
Outcome; estimate type | Baseline difference Est [95% CI] P-value | Week 18 difference* Est [95% CI] P-value |
|---|---|---|
10-Time Chair Rise Test | ||
 Unable to complete due to physical ability or safety concerns; OR | 2.1 [0.7, 7.4] P = 0.20 |  |
 Time to complete; seconds | 5.6 [0.2, 11.1] P = 0.04 |  |
 Change in time to complete from week 2/6; seconds |  | 0 [−3.2, 4.1] P = 0.81 |
Clinical Frailty Scale | ||
 Post-hospitalization reported frailty; OR | 0.8 [0.2, 2.5] P = 0.67 |  |
 Did not return to pre-hospitalization frailty; OR |  | 3.4 [1.2, 10.6] P = 0.03 |
MRC Dyspnea Scale | ||
 Too SOB to leave the house and/or SOB while dressing; OR | 2.0 [0.8, 5.3] P = 0.13 |  |
 No improvement from week 2–6 answer; OR |  | 1.6 [0.6, 4.9] P = 0.37 |
IES-6 | ||
 Met criteria for PTSD; OR | 1.3 [0.5, 3.5] P = 0.53 |  |
 Continued or new PTSD; OR |  | 2.7 [0.9, 9.6] P = 0.10 |
WHODAS 2.0 | ||
 Total score | 4.4 [−0.3, 9.1] P = 0.06 |  |
 Difference from week 2–6; score |  | 3.1 [−1.8, 8.1] P = 0.21 |
Supplemental O2 | ||
 Reported use; OR | 2.0 [0.9, 4.5] P = 0.10 |  |
 Continued or new use of supplemental O2; OR |  | 4.8 [1.5, 19.0] P = 0.01 |
Activity Level | ||
 Did not return to pre-hospitalization exercise; OR |  | 1.2 [0.4, 3.8] P = 0.8 |